Cabot (NYSE:CBT) Updates FY 2025 Earnings Guidance

Cabot (NYSE:CBT) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share guidance of 7.400-7.800 for the period, compared to the consensus earnings per share estimate of 7.060. The company issued revenue guidance of -. Cabot also updated its FY25 guidance to $7.40-7.80 EPS.

Cabot Stock Up 6.9 %

Shares of NYSE CBT traded up $7.51 during trading hours on Wednesday, hitting $116.37. The company had a trading volume of 331,254 shares, compared to its average volume of 337,930. The company has a quick ratio of 1.45, a current ratio of 2.22 and a debt-to-equity ratio of 0.72. Cabot has a 1-year low of $68.11 and a 1-year high of $117.37. The stock has a market capitalization of $6.38 billion, a P/E ratio of 12.95, a price-to-earnings-growth ratio of 0.91 and a beta of 1.20. The firm’s 50 day moving average is $108.41 and its 200-day moving average is $101.13.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Monday, November 4th. The specialty chemicals company reported $1.80 EPS for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01). The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $1.01 billion. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.65 EPS. On average, analysts expect that Cabot will post 7.07 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on CBT shares. JPMorgan Chase & Co. lifted their price objective on Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 7th. UBS Group decreased their price objective on Cabot from $103.00 to $98.00 and set a “neutral” rating for the company in a report on Tuesday, August 6th. Finally, Mizuho lifted their target price on Cabot from $103.00 to $122.00 and gave the company an “outperform” rating in a research report on Tuesday. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $105.00.

Insider Activity at Cabot

In other news, EVP Jeff Ji Zhu sold 1,201 shares of Cabot stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $106.19, for a total value of $127,534.19. Following the sale, the executive vice president now directly owns 96,000 shares of the company’s stock, valued at approximately $10,194,240. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Cabot news, CEO Sean D. Keohane sold 25,617 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the sale, the chief executive officer now directly owns 331,174 shares of the company’s stock, valued at $33,630,719.70. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Jeff Ji Zhu sold 1,201 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $106.19, for a total value of $127,534.19. Following the transaction, the executive vice president now owns 96,000 shares of the company’s stock, valued at $10,194,240. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,665 shares of company stock worth $4,986,299. Corporate insiders own 3.07% of the company’s stock.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.